| Contributors |
|
vi | |
| Preface |
|
x | |
|
SECTION I General Considerations of Hospital Infections |
|
|
1 | (276) |
|
1 Epidemiology of Healthcare-Associated Infections |
|
|
1 | (18) |
|
|
|
|
|
2 The Healthcare Epidemiologist |
|
|
19 | (5) |
|
|
|
|
|
|
|
24 | (15) |
|
|
|
|
|
4 Occupational Infection Prevention and Control Services |
|
|
39 | (18) |
|
|
|
|
|
5 The Development of Infection Prevention and Surveillance Programs |
|
|
57 | (7) |
|
|
|
|
|
6 Surveillance of Healthcare-Associated Infections |
|
|
64 | (14) |
|
|
|
7 Comparison of Methods Used by Partners of the Transatlantic Taskforce on Antimicrobial Resistance to Conduct Prevalence Surveys of Healthcare-Associated Infections |
|
|
78 | (8) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8 Investigating Endemic and Epidemic Healthcare-Associated Infections |
|
|
86 | (21) |
|
|
|
9 Epidemiologic Methods for Investigating Infections in the Healthcare Setting |
|
|
107 | (9) |
|
|
|
10 The Role of the Laboratory in Prevention of Healthcare-Associated Infections |
|
|
116 | (22) |
|
|
|
|
|
11 The Practice of Epidemiology in Community Hospitals |
|
|
138 | (11) |
|
|
|
|
|
12 The Role of Professional, Governmental, and Regulatory Organizations in Infection Prevention and Control |
|
|
149 | (18) |
|
|
|
13 Antimicrobial Stewardship: Programmatic Efforts to Optimize Antimicrobial Use |
|
|
167 | (10) |
|
|
|
|
|
14 Multidrug-Resistant Organisms: Epidemiology and Control |
|
|
177 | (27) |
|
|
|
|
|
|
|
15 Molecular Biology of Resistance: A Brief History of Resistance Mechanisms and the Discovery of Gene Transfer |
|
|
204 | (13) |
|
|
|
|
|
16 Economic Evaluation of Healthcare-Associated Infections and Infection Control and Antimicrobial Stewardship Interventions |
|
|
217 | (12) |
|
|
|
|
|
|
|
17 Epidemiology, Prevention, and Control of Healthcare-Acquired Infections in Limited-Resource Settings |
|
|
229 | (48) |
|
|
|
SECTION II Functional Areas of Concern |
|
|
277 | (172) |
|
18 The Inanimate Environment |
|
|
277 | (18) |
|
|
|
19 Disinfection and Sterilization in Healthcare Facilities |
|
|
295 | (25) |
|
|
|
|
|
20 Foodborne Disease Prevention in Healthcare Facilities |
|
|
320 | (10) |
|
|
|
21 Clinical Laboratory--Acquired Infections |
|
|
330 | (9) |
|
|
|
|
|
22 Dialysis-Associated Complications and Their Control |
|
|
339 | (25) |
|
|
|
|
|
|
|
23 The Intensive Care Unit: Antibiotic Resistance and Prevention of Central Venous Catheter-Associated Bloodstream Infections, Catheter-Associated Urinary Tract Infections, and Clostridioides difficile |
|
|
364 | (20) |
|
|
|
|
|
|
|
|
|
24 The Newborn Nursery and the Neonatal Intensive Care Unit |
|
|
384 | (24) |
|
|
|
|
|
25 The Perioperative Suite |
|
|
408 | (14) |
|
|
|
|
|
|
|
26 Ambulatory Care Settings |
|
|
422 | (14) |
|
|
|
27 Infections in Long-Term Care Facilities |
|
|
436 | (13) |
|
|
|
SECTION III Endemic and Epidemic Hospital Infections |
|
|
449 | (400) |
|
28 Incidence and Nature of Endemic and Epidemic Healthcare-Associated Infections |
|
|
449 | (26) |
|
|
|
|
|
|
|
29 Urinary Tract Infections |
|
|
475 | (10) |
|
|
|
|
|
|
|
30 Hospital-Acquired Pneumonia |
|
|
485 | (9) |
|
|
|
31 Nosocomial Tuberculosis |
|
|
494 | (17) |
|
|
|
|
|
32 Infectious Gastroenteritis |
|
|
511 | (19) |
|
|
|
|
|
33 Central Nervous System Infections |
|
|
530 | (11) |
|
|
|
34 Surgical Site Infection: Epidemiology, Pathogenesis, Risk Factors and Evidence-Based Interventional Strategies |
|
|
541 | (25) |
|
|
|
|
|
|
|
|
|
|
|
35 Burn Wound Infection and Sepsis in the Patient With Burns |
|
|
566 | (11) |
|
|
|
|
|
|
|
36 Infections due to Infusion Therapy |
|
|
577 | (34) |
|
|
|
|
|
|
|
37 Infections of Implantable Cardiac and Vascular Devices |
|
|
611 | (25) |
|
|
|
38 Infections in Skeletal Prostheses and Allografts |
|
|
636 | (12) |
|
|
|
|
|
|
|
|
|
|
|
39 The Importance of Infection Control Measures in Controlling Multidrug-Resistant Organisms |
|
|
648 | (17) |
|
|
|
40 Healthcare-Associated Respiratory Viral Infections |
|
|
665 | (14) |
|
|
|
|
|
41 Preventing the Transmission of Blood-Borne Pathogens in the Healthcare Setting |
|
|
679 | (24) |
|
|
|
42 Healthcare-Associated Fungal Infections |
|
|
703 | (21) |
|
|
|
|
|
43 Healthcare-Associated Infections in Transplant Recipients |
|
|
724 | (31) |
|
|
|
|
|
|
|
44 Miscellaneous Procedure-Related Infections |
|
|
755 | (30) |
|
|
|
|
|
45 Public Reporting of Healthcare-Associated Infection Rates |
|
|
785 | (10) |
|
|
|
|
|
|
|
|
|
795 | (6) |
|
|
|
47 Peripheral Venous Catheters |
|
|
801 | (34) |
|
|
|
|
|
48 The Coronaviruses-SARS-CoV-l, MERS-CoV, and SARS-CoV-2 (COVID-19) |
|
|
835 | (14) |
|
|
|
|
| Index |
|
849 | |